Form 4 Filing for Edesa Biotech, Inc. - Officer/Director Transaction

Pardeep Nijhawan, Chief Executive Officer, Director, and 10% Owner of Edesa Biotech, Inc., acquired 1159 shares of Common Stock on May 1, 2026, at a price of $0.0 per share. This transaction was part of a grant of restricted share units that vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. Following this transaction, Nijhawan directly holds 632,550 shares. Additionally, shares are held indirectly through various entities: 402,702 shares through Pardeep Medicine Professional Corporation, 32,609 shares through The New Nijhawan Family Trust 2015, 32,013 shares through The Digestive Health Clinic Inc., and 53,104 shares through 1968160Ontario Inc. Nijhawan disclaims beneficial ownership of the indirectly held shares except to the extent of his pecuniary interest.